Search Results - "Rameshwari Ammal Kannan, Thiraviam Pillai"
-
1
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
Published in Vaccine (04-01-2023)“…The recent World Health Organization recommendation supporting single-dose of HPV vaccine will significantly reduce programmatic cost, mitigate the supply…”
Get full text
Journal Article -
2
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
Published in The lancet oncology (01-11-2021)“…A randomised trial designed to compare three and two doses of quadrivalent human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a…”
Get full text
Journal Article -
3
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
Published in The lancet oncology (2016)“…Summary Background An increase in worldwide HPV vaccination could be facilitated if fewer than three doses of vaccine are as effective as three doses. We…”
Get full text
Journal Article -
4
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination
Published in Journal of the National Cancer Institute. Monographs (01-11-2024)“…Abstract Background While recommending a human papillomavirus (HPV) single-dose vaccination schedule in 2022, the World Health Organization highlighted the…”
Get full text
Journal Article -
5
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study
Published in PloS one (29-12-2020)“…In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as…”
Get full text
Journal Article -
6
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine
Published in Human vaccines & immunotherapeutics (15-12-2023)“…Long-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an…”
Get full text
Journal Article -
7
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
Published in Papillomavirus research (01-06-2019)“…Earlier publication from the ongoing multi-centric study of the International Agency for Research on Cancer to evaluate less than three doses of the…”
Get full text
Journal Article -
8
Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India
Published in Papillomavirus research (01-06-2018)“…Extending two-dose recommendations of HPV vaccine to girls between 15 and 18 years will reduce program cost and improve compliance. Immunogenicity and vaccine…”
Get full text
Journal Article